Intermediate-Risk and High-Risk Pulmonary Embolism: Recognition and Management: Cardiology Clinics: Cardiac Emergencies.
Catheter-directed therapy
Pulmonary embolism
Pulmonary embolism response team (PERT)
Risk stratification
Thrombolysis
Journal
Cardiology clinics
ISSN: 1558-2264
Titre abrégé: Cardiol Clin
Pays: Netherlands
ID NLM: 8300331
Informations de publication
Date de publication:
May 2024
May 2024
Historique:
medline:
18
4
2024
pubmed:
18
4
2024
entrez:
17
4
2024
Statut:
ppublish
Résumé
Pulmonary embolism (PE) is the third most common cause of cardiovascular death. Every specialty of medical practitioner will encounter PE in their patients, and should be prepared to employ contemporary strategies for diagnosis and initial risk-stratification. Treatment of PE is based on risk-stratification, with anticoagulation for all patients, and advanced modalities including systemic thrombolysis, catheter-directed therapies, and mechanical circulatory supports utilized in a manner paralleling PE severity and clinical context.
Identifiants
pubmed: 38631791
pii: S0733-8651(24)00018-3
doi: 10.1016/j.ccl.2024.02.008
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
215-235Informations de copyright
Copyright © 2024 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure Dr. Drew Birrenkott has no disclosures. Dr. Dudzinski has no disclosures. Dr. Kabrhel reports Grants (paid to my institution): Grifols, Diagnostica Stago Consulting/Advisory Boards: Siemens, BMS/Pfizer, Abbot Equity: Insera Therapeutics.